ARCHIVES

Hyperthermia, Radiation Enhancement, New Drugs Offer More Therapy Advances, ASCO Members Hear

This article is from The Cancer Letter archive.

Vol. 04 No. 14 | April 7, 1978

Download PDF Visit The Full Archive

Related Articles

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget

December 7, 2012

Court Forces CPSC To Reopen Carcinogen Policy

January 19, 1979

NCI “Much Stronger” Now, Rimer Says In Note To Staff.

September 21, 2001

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge

March 27, 1981